GLP-1 Plateaus: Why Weight Loss Slows Down and What to Do Next
Weight loss often slows after months on Ozempic, Wegovy, Mounjaro, or Zepbound. Learn why GLP-1 plateaus happen and what to discuss next.
Evidence-based articles about GLP-1 medications, written for patients and reviewed by healthcare professionals.
Weight loss often slows after months on Ozempic, Wegovy, Mounjaro, or Zepbound. Learn why GLP-1 plateaus happen and what to discuss next.
Semaglutide and tirzepatide trials show lean mass can account for ~25-40% of weight lost. Reviewer-vetted protocol — resistance training, ≥1.6 g/kg protein, sleep, creatine — to reduce muscle loss.
Weight often returns after stopping a GLP-1. STEP 4 and SURMOUNT-4 show how much, how fast, and what may help protect progress.
How GLP-1 drugs like Ozempic and Mounjaro may interact with alcohol, emerging research on reduced cravings, and practical guidance.
Common and rare GLP-1 side effects, how often they occur in trials, tips for managing nausea and GI symptoms, and when to call your doctor.
Realistic timelines for GLP-1 weight loss and A1C improvement, from first weeks through 12+ months, based on STEP and SURMOUNT trial data.
Comparing Rybelsus (oral semaglutide) with injectable GLP-1 options like Ozempic and Wegovy on efficacy, convenience, cost, and more.
Oral Wegovy (semaglutide 25 mg tablet) was FDA-approved December 2025. How does it compare to injectable Wegovy (2.4 mg) for weight loss, side effects, and cost?